Biotech companies have been some of the hottest IPOs in recent years. This week, Josh Nathan-Kasiz joins host Alex Eule on The Readback to talk about one of biotech's most promising treatments. The Readback is a finance and business podcast from Barron's. Producer: Mette Lützhøft.

Learn more about your ad choices. Visit megaphone.fm/adchoices